BioDelivery Sciences International (BDSI)
BioDelivery Sciences International Market Cap: 116.55M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BDSI Market Cap Rankings
| Overall | 25th percentile | 3484 of 4649 |
| Sector | 32nd percentile | 353 of 525 in Healthcare |
| Industry | 34th percentile | 106 of 163 in Biotechnology |
BDSI Market Cap Range, Past 5 Years
| Minimum | 23.80M | Dec 2011 |
| Maximum | 138.68M | Jun 2009 |
| Average | 71.95M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these BDSI related companies
BDSI News
BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U.
May 21, 7:00AM Benzinga
May 21, 7:00AM Benzinga
BioDelivery Sciences reported 1st Qtr earnings of $0.69 per share on 05/11/2012 Picked up a few $BDSI http://chart.ly/xaj9n4b
about 12 days ago by TechEdgeTrades
about 12 days ago by TechEdgeTrades
$GRPN http://stks.co/3p49 $GRPN $RPRX $VTUS $XNPT $BDSI $KERX Full post here http://stks.co/3p4A
about 13 days ago by LincolnList
about 13 days ago by LincolnList
$BDSI Upside Blowoff - 15 Minute Down Reversal - Red bar after 4 green bars
about 13 days ago by TradeIdeasQuant
about 13 days ago by TradeIdeasQuant
Vertex Pharmaceuticals Incorporated, Medivation Among Stocks Hitting 52-Week Highs Monday
May 14, 12:32PM Fox Business
May 14, 12:32PM Fox Business
UPDATE: Ladenburg Thalmann Maintains Buy Rating, Raises PT for BioDelivery Sciences International
May 14, 11:16AM Benzinga
May 14, 11:16AM Benzinga
@JNapodano $POZN, 8K http://stks.co/3mIx Good chart a la $BDSI, except for the drop prior to press conference. Brazil approval also brewing
about 17 days ago by Glopolon
about 17 days ago by Glopolon
$bdsi, the one that got away! This stock has been doing big things this year!
about 19 days ago by ChasinCheddar
about 19 days ago by ChasinCheddar
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
May 09, 7:00AM PR Newswire
May 09, 7:00AM PR Newswire
Short-term targets: $BDSI expect a run to 4 range. $LNG look for 22-23 zone. $MIPS 8 1/4-1/2. $SSYS could see 52-53. http://stks.co/3OkA
about 39 days ago by thetechtrader
about 39 days ago by thetechtrader
BioDelivery Sciences Awarded Patent Resulting in $15 Million Milestone Payment
Apr 17, 7:05AM Benzinga
Apr 17, 7:05AM Benzinga
BioDelivery (BDSI) Receives U.S. Patent for BEMA Products; Gets $15M Milestone
Apr 17, 7:04AM Street Insider
Apr 17, 7:04AM Street Insider
BioDelivery Sciences to Present at the Future Leaders in the Biotech Industry Conference
Apr 16, 8:00AM PR Newswire
Apr 16, 8:00AM PR Newswire
BioDelivery Sciences to Host Opioid Dependence Investor Event and Webcast on April 11, 2012
Apr 05, 8:00AM PR Newswire
Apr 05, 8:00AM PR Newswire
@peterumble Thanks Pete! $bdsi, I didn't wait until the $3 target but I made some money!
about 54 days ago by ChasinCheddar
about 54 days ago by ChasinCheddar
Up 20% on $bdsi, looking to get out soon, take profits. I do think this stock is going to climb higher though!
about 55 days ago by ChasinCheddar
about 55 days ago by ChasinCheddar
Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation
Mar 14, 7:00AM PR Newswire
Mar 14, 7:00AM PR Newswire
BioDelivery Sciences (BDSI) Gets Favorable Outcome in Patent Dispute with MonoSol
Mar 06, 9:45AM Street Insider
Mar 06, 9:45AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BDSI | 3.94 | -0.14 | -3.43% | 116.55M |
| BDR | 1.00 | +0.00 | +0.00% | 6.21M |
| BDN | 11.29 | -0.07 | -0.62% | 1.611B |
| BPFH | 8.99 | +0.02 | +0.22% | 702.48M |
| BPAX | 0.5183 | -0.00 | -0.25% | 62.63M |
| BP | 38.36 | +0.13 | +0.34% | 121.32B |
| BOXC | 25.90 | +0.49 | +1.93% | |
| BOX | 18.08 | -0.22 | -1.20% | 366.84M |
| BOSC | 0.7601 | -0.00 | -0.51% | 3.398M |
| BKBK | 8.12 | +0.00 | +0.00% | 17.38M |
